Life Science Market

研究執行與發布：Coherent Market Insights　·　發布日期 2026-01-27　·　168 頁
由量子訊息有限公司（Quantum Information）在台灣代理銷售與提供授權諮詢。

2026 年市場規模: USD 108.80 Bn
2033 年預估規模: USD 245.07 Bn
年複合成長率 CAGR: 12.3%

以上數字由 Coherent Market Insights 於本報告中提出，量子訊息原樣引用。

出版商 Coherent Market Insights 產業別 Healthcare & Life Sciences出版日期 2026-01-27頁數 168報告編號 CMI9258

授權報價

Single User Price	$4,500 USD
Enterprise License	$10,000 USD

洽詢購買申請 Sample

完整報告名稱與涵蓋範圍

Life Science Market, By Product Type (Pharmaceutical Products, Biopharmaceuticals, Medical Devices, Diagnostic Products, Nutraceuticals, Laboratory Equipment & Supplies, and Others (Research Chemicals)), By Application (Drug Discovery, Genomics, Proteomics, Cell Biology, Microbiology, and Molecular Diagnostics), By End User (Academic and Research Institutes, Pharmaceutical and Biotech Companies, Hospitals and Diagnostic Centers, Contract Research Organizations (CROs), and Government Agencies), By Technology (Genomic Sequencing, CRISPR Technology, Mass Spectrometry, Microscopy, Flow Cytometry, and Polymerase Chain Reaction (PCR)), By Therapeutic Area (Oncology, Cardiovascular, Neurology, Infectious Diseases, Immunology, and Rare Diseases), By Distribution Channel (Online and Offline), By Geography (North America, Europe, Asia Pacific, Latin America, Middle East, and Africa)

報告摘要

According to Coherent Market Insights, the life science market is estimated to be valued at USD 108.80 Bn in 2026 and is expected to reach USD 245.07 Bn by 2033, exhibiting a compound annual growth rate (CAGR) of 12.3% from 2026 to 2033. The global life science market represents a dynamic and rapidly evolving sector encompassing pharmaceuticals, biotechnology, medical devices, diagnostics, and related healthcare services that collectively drive innovation in human health and wellness. This multifaceted industry serves as the backbone of modern healthcare systems worldwide, continuously advancing through groundbreaking research, technological innovations, and strategic collaborations between academic institutions, private enterprises, and government organizations. The market has experienced unprecedented growth momentum, particularly accelerated by recent global health challenges that have highlighted the critical importance of robust life science capabilities in addressing emerging diseases, developing novel therapeutic solutions, and enhancing diagnostic precision. Key segments within this expansive market include drug discovery and development, clinical research services, laboratory equipment and consumables, biomanufacturing technologies, and digital health solutions that collectively contribute to improving patient outcomes and extending human longevity. The industry's evolution is characterized by increasing investment in personalized medicine, gene therapy, immunotherapy, and artificial intelligence-driven drug discovery platforms, positioning life sciences at the forefront of technological advancement and creating substantial opportunities for stakeholders across the healthcare value chain. Market Dynamics The global life science market is propelled by several compelling drivers that collectively fuel its sustained expansion and innovation trajectory. Aging global populations, increasing prevalence of chronic diseases, and rising healthcare awareness create substantial demand for advanced therapeutic solutions and diagnostic technologies, while significant investments in research and development activities by both private and public sectors accelerate the discovery and commercialization of breakthrough treatments. Government initiatives supporting healthcare infrastructure development, favorable regulatory frameworks for drug approvals, and growing adoption of precision medicine approaches further stimulate market growth. However, the market faces notable restraints including stringent regulatory requirements that extend product development timelines, substantial capital investments required for research and development activities, and complex intellectual property challenges that can limit market entry for smaller players. Additionally, pricing pressures from healthcare payers, lengthy clinical trial processes, and potential safety concerns associated with novel therapies create barriers to market expansion. Despite these challenges, the market presents significant opportunities driven by emerging technologies such as artificial intelligence in drug discovery, expanding applications of gene and cell therapies, growing demand for personalized medicine solutions, and increasing healthcare expenditure in developing economies. The integration of digital health technologies, expansion into underserved therapeutic areas, strategic partnerships between pharmaceutical companies and technology firms, and the development of novel delivery mechanisms for existing drugs create additional avenues for market growth and innovation. Key Features of the Study • This report provides in-depth analysis of the global life science market, and provides market size (USD Billion) and compound annual growth rate (CAGR%) for the forecast period (2026–2033), considering 2025 as the base year • It elucidates potential revenue opportunities across different segments and explains attractive investment proposition matrices for this market • This study also provides key insights about market drivers, restraints, opportunities, new product launches or approvals, market trends, regional outlook, and competitive strategies adopted by key players • It profiles key players in the global life science market based on the following parameters – company highlights, products portfolio, key highlights, financial performance, and strategies • Key companies covered as a part of this study include Thermo Fisher Scientific, Siemens Healthineers, Abbott Laboratories, GE Healthcare, Roche Diagnostics, Medtronic, Philips Healthcare, Johnson & Johnson, Becton Dickinson, Danaher Corporation, PerkinElmer, Sartorius, Merck Group, Illumina, and Agilent Technologies • Insights from this report would allow marketers and the management authorities of the companies to make informed decisions regarding their future product launches, type up-gradation, market expansion, and marketing tactics • The global life science market report caters to various stakeholders in this industry including investors, suppliers, product manufacturers, distributors, new entrants, and financial analysts • Stakeholders would have ease in decision-making through various strategy matrices used in analyzing the global life science market Market Segmentation • Product Type Insights (Revenue, USD Bn, 2021 - 2033) o Pharmaceutical Products o Biopharmaceuticals o Medical Devices o Diagnostic Products o Nutraceuticals o Laboratory Equipment & Supplies o Others (Research Chemicals) • Application Insights (Revenue, USD Bn, 2021 - 2033) o Drug Discovery o Genomics o Proteomics o Cell Biology o Microbiology o Molecular Diagnostics • End User Insights (Revenue, USD Bn, 2021 - 2033) o Academic and Research Institutes o Pharmaceutical and Biotech Companies o Hospitals and Diagnostic Centers o Contract Research Organizations (CROs) o Government Agencies • Technology Insights (Revenue, USD Bn, 2021 - 2033) o Genomic Sequencing o CRISPR Technology o Mass Spectrometry o Microscopy o Flow Cytometry o Polymerase Chain Reaction (PCR) • Therapeutic Area Insights (Revenue, USD Bn, 2021 - 2033) o Oncology o Cardiovascular o Neurology o Infectious Diseases o Immunology o Rare Diseases • Distribution Channel Insights (Revenue, USD Bn, 2021 - 2033) o Online o Offline • Regional Insights (Revenue, USD Bn, 2021 - 2033) o North America  U.S.  Canada o Latin America  Brazil  Argentina  Mexico  Rest of Latin America o Europe  Germany  U.K.  Spain  France  Italy  Russia  Rest of Europe o Asia Pacific  China  India  Japan  Australia  South Korea  ASEAN  Rest of Asia Pacific o Middle East  GCC Countries  Israel  Rest of Middle East o Africa  South Africa  North Africa  Central Africa • Key Players Insights o Thermo Fisher Scientific o Siemens Healthineers o Abbott Laboratories o GE Healthcare o Roche Diagnostics o Medtronic o Philips Healthcare o Johnson & Johnson o Becton Dickinson o Danaher Corporation o PerkinElmer o Sartorius o Merck Group o Illumina o Agilent Technologies

目錄 Table of Contents

Table of Contents 1. Research Objectives and Assumptions o Research Objectives o Assumptions o Abbreviations 2. Market Purview o Report Description  Market Definition and Scope o Executive Summary  Global Life Science Market, By Product Type  Global Life Science Market, By Application  Global Life Science Market, By End User  Global Life Science Market, By Technology  Global Life Science Market, By Therapeutic Area  Global Life Science Market, By Distribution Channel  Global Life Science Market, By Region 3. Market Dynamics, Regulations, and Trends Analysis o Market Dynamics o Impact Analysis o Key Highlights o Regulatory Scenario o Product Launches/Approvals o PEST Analysis o PORTER’s Analysis o Market Opportunities o Regulatory Scenario o Key Developments o Industry Trends 4. Global Life Science Market, By Product Type, 2021-2033, (USD Bn) o Introduction  Market Share Analysis, 2026 and 2033 (%)  Y-o-Y Growth Analysis, 2022 - 2033  Segment Trends o Pharmaceutical Products  Introduction  Market Size and Forecast, and Y-o-Y Growth, 2021-2033, (USD Bn) o Biopharmaceuticals  Introduction  Market Size and Forecast, and Y-o-Y Growth, 2021-2033, (USD Bn) o Medical Devices  Introduction  Market Size and Forecast, and Y-o-Y Growth, 2021-2033, (USD Bn) o Diagnostic Products  Introduction  Market Size and Forecast, and Y-o-Y Growth, 2021-2033, (USD Bn) o Nutraceuticals  Introduction  Market Size and Forecast, and Y-o-Y Growth, 2021-2033, (USD Bn) o Laboratory Equipment & Supplies  Introduction  Market Size and Forecast, and Y-o-Y Growth, 2021-2033, (USD Bn) o Others (Research Chemicals)  Introduction  Market Size and Forecast, and Y-o-Y Growth, 2021-2033, (USD Bn) 5. Global Life Science Market, By Application, 2021-2033, (USD Bn) o Introduction  Market Share Analysis, 2026 and 2033 (%)  Y-o-Y Growth Analysis, 2022 - 2033  Segment Trends o Drug Discovery  Introduction  Market Size and Forecast, and Y-o-Y Growth, 2021-2033, (USD Bn) o Genomics  Introduction  Market Size and Forecast, and Y-o-Y Growth, 2021-2033, (USD Bn) o Proteomics  Introduction  Market Size and Forecast, and Y-o-Y Growth, 2021-2033, (USD Bn) o Cell Biology  Introduction  Market Size and Forecast, and Y-o-Y Growth, 2021-2033, (USD Bn) o Microbiology  Introduction  Market Size and Forecast, and Y-o-Y Growth, 2021-2033, (USD Bn) o Molecular Diagnostics  Introduction  Market Size and Forecast, and Y-o-Y Growth, 2021-2033, (USD Bn) 6. Global Life Science Market, By End User, 2021-2033, (USD Bn) o Introduction  Market Share Analysis, 2026 and 2033 (%)  Y-o-Y Growth Analysis, 2022 - 2033  Segment Trends o Academic and Research Institutes  Introduction  Market Size and Forecast, and Y-o-Y Growth, 2021-2033, (USD Bn) o Pharmaceutical and Biotech Companies  Introduction  Market Size and Forecast, and Y-o-Y Growth, 2021-2033, (USD Bn) o Hospitals and Diagnostic Centers  Introduction  Market Size and Forecast, and Y-o-Y Growth, 2021-2033, (USD Bn) o Contract Research Organizations (CROs)  Introduction  Market Size and Forecast, and Y-o-Y Growth, 2021-2033, (USD Bn) o Government Agencies  Introduction  Market Size and Forecast, and Y-o-Y Growth, 2021-2033, (USD Bn) 7. Global Life Science Market, By Technology, 2021-2033, (USD Bn) o Introduction  Market Share Analysis, 2026 and 2033 (%)  Y-o-Y Growth Analysis, 2022 - 2033  Segment Trends o Genomic Sequencing  Introduction  Market Size and Forecast, and Y-o-Y Growth, 2021-2033, (USD Bn) o CRISPR Technology  Introduction  Market Size and Forecast, and Y-o-Y Growth, 2021-2033, (USD Bn) o Mass Spectrometry  Introduction  Market Size and Forecast, and Y-o-Y Growth, 2021-2033, (USD Bn) o Microscopy  Introduction  Market Size and Forecast, and Y-o-Y Growth, 2021-2033, (USD Bn) o Flow Cytometry  Introduction  Market Size and Forecast, and Y-o-Y Growth, 2021-2033, (USD Bn) o Polymerase Chain Reaction (PCR)  Introduction  Market Size and Forecast, and Y-o-Y Growth, 2021-2033, (USD Bn) 8. Global Life Science Market, By Therapeutic Area, 2021-2033, (USD Bn) o Introduction  Market Share Analysis, 2026 and 2033 (%)  Y-o-Y Growth Analysis, 2022 - 2033  Segment Trends o Oncology  Introduction  Market Size and Forecast, and Y-o-Y Growth, 2021-2033, (USD Bn) o Cardiovascular  Introduction  Market Size and Forecast, and Y-o-Y Growth, 2021-2033, (USD Bn) o Neurology  Introduction  Market Size and Forecast, and Y-o-Y Growth, 2021-2033, (USD Bn) o Infectious Diseases  Introduction  Market Size and Forecast, and Y-o-Y Growth, 2021-2033, (USD Bn) o Immunology  Introduction  Market Size and Forecast, and Y-o-Y Growth, 2021-2033, (USD Bn) o Rare Diseases  Introduction  Market Size and Forecast, and Y-o-Y Growth, 2021-2033, (USD Bn) 9. Global Life Science Market, By Distribution Channel, 2021-2033, (USD Bn) o Introduction  Market Share Analysis, 2026 and 2033 (%)  Y-o-Y Growth Analysis, 2022 - 2033  Segment Trends o Online  Introduction  Market Size and Forecast, and Y-o-Y Growth, 2021-2033, (USD Bn) o Offline  Introduction  Market Size and Forecast, and Y-o-Y Growth, 2021-2033, (USD Bn) 10. Global Life Science Market, By Region, 2021 - 2033, Value (USD Bn) o Introduction  Market Share (%) Analysis, 2026, 2029 & 2033, Value (USD Bn)  Market Y-o-Y Growth Analysis (%), 2022 - 2033, Value (USD Bn)  Regional Trends o North America  Introduction  Market Size and Forecast, By Product Type, 2021 - 2033, Value (USD Bn)  Market Size and Forecast, By Application, 2021 - 2033, Value (USD Bn)  Market Size and Forecast, By End User, 2021 - 2033, Value (USD Bn)  Market Size and Forecast, By Technology, 2021 - 2033, Value (USD Bn)  Market Size and Forecast, By Therapeutic Area, 2021 - 2033, Value (USD Bn)  Market Size and Forecast, By Distribution Channel, 2021 - 2033, Value (USD Bn)  Market Size and Forecast, By Country, 2021 - 2033, Value (USD Bn) o U.S. o Canada o Latin America  Introduction  Market Size and Forecast, By Product Type, 2021 - 2033, Value (USD Bn)  Market Size and Forecast, By Application, 2021 - 2033, Value (USD Bn)  Market Size and Forecast, By End User, 2021 - 2033, Value (USD Bn)  Market Size and Forecast, By Technology, 2021 - 2033, Value (USD Bn)  Market Size and Forecast, By Therapeutic Area, 2021 - 2033, Value (USD Bn)  Market Size and Forecast, By Distribution Channel, 2021 - 2033, Value (USD Bn)  Market Size and Forecast, By Country, 2021 - 2033, Value (USD Bn) o Brazil o Argentina o Mexico o Rest of Latin America o Europe  Introduction  Market Size and Forecast, By Product Type, 2021 - 2033, Value (USD Bn)  Market Size and Forecast, By Application, 2021 - 2033, Value (USD Bn)  Market Size and Forecast, By End User, 2021 - 2033, Value (USD Bn)  Market Size and Forecast, By Technology, 2021 - 2033, Value (USD Bn)  Market Size and Forecast, By Therapeutic Area, 2021 - 2033, Value (USD Bn)  Market Size and Forecast, By Distribution Channel, 2021 - 2033, Value (USD Bn)  Market Size and Forecast, By Country, 2021 - 2033, Value (USD Bn) o Germany o U.K. o Spain o France o Italy o Russia o Rest of Europe o Asia Pacific  Introduction  Market Size and Forecast, By Product Type, 2021 - 2033, Value (USD Bn)  Market Size and Forecast, By Application, 2021 - 2033, Value (USD Bn)  Market Size and Forecast, By End User, 2021 - 2033, Value (USD Bn)  Market Size and Forecast, By Technology, 2021 - 2033, Value (USD Bn)  Market Size and Forecast, By Therapeutic Area, 2021 - 2033, Value (USD Bn)  Market Size and Forecast, By Distribution Channel, 2021 - 2033, Value (USD Bn)  Market Size and Forecast, By Country, 2021 - 2033, Value (USD Bn) o China o India o Japan o Australia o South Korea o ASEAN o Rest of Asia Pacific o Middle East  Introduction  Market Size and Forecast, By Product Type, 2021 - 2033, Value (USD Bn)  Market Size and Forecast, By Application, 2021 - 2033, Value (USD Bn)  Market Size and Forecast, By End User, 2021 - 2033, Value (USD Bn)  Market Size and Forecast, By Technology, 2021 - 2033, Value (USD Bn)  Market Size and Forecast, By Therapeutic Area, 2021 - 2033, Value (USD Bn)  Market Size and Forecast, By Distribution Channel, 2021 - 2033, Value (USD Bn)  Market Size and Forecast, By Country, 2021 - 2033, Value (USD Bn) o GCC Countries o Israel o Rest of Middle East o Africa  Introduction  Market Size and Forecast, By Product Type, 2021 - 2033, Value (USD Bn)  Market Size and Forecast, By Application, 2021 - 2033, Value (USD Bn)  Market Size and Forecast, By End User, 2021 - 2033, Value (USD Bn)  Market Size and Forecast, By Technology, 2021 - 2033, Value (USD Bn)  Market Size and Forecast, By Therapeutic Area, 2021 - 2033, Value (USD Bn)  Market Size and Forecast, By Distribution Channel, 2021 - 2033, Value (USD Bn)  Market Size and Forecast, By Country/Region, 2021 - 2033, Value (USD Bn) o South Africa o North Africa o Central Africa 11. Competitive Landscape o Thermo Fisher Scientific  Company Highlights  Product Portfolio  Key Developments  Financial Performance  Strategies o Siemens Healthineers  Company Highlights  Product Portfolio  Key Developments  Financial Performance  Strategies o Abbott Laboratories  Company Highlights  Product Portfolio  Key Developments  Financial Performance  Strategies o GE Healthcare  Company Highlights  Product Portfolio  Key Developments  Financial Performance  Strategies o Roche Diagnostics  Company Highlights  Product Portfolio  Key Developments  Financial Performance  Strategies o Medtronic  Company Highlights  Product Portfolio  Key Developments  Financial Performance  Strategies o Philips Healthcare  Company Highlights  Product Portfolio  Key Developments  Financial Performance  Strategies o Johnson & Johnson  Company Highlights  Product Portfolio  Key Developments  Financial Performance  Strategies o Becton Dickinson  Company Highlights  Product Portfolio  Key Developments  Financial Performance  Strategies o Danaher Corporation  Company Highlights  Product Portfolio  Key Developments  Financial Performance  Strategies o PerkinElmer  Company Highlights  Product Portfolio  Key Developments  Financial Performance  Strategies o Sartorius  Company Highlights  Product Portfolio  Key Developments  Financial Performance  Strategies o Merck Group  Company Highlights  Product Portfolio  Key Developments  Financial Performance  Strategies o Illumina  Company Highlights  Product Portfolio  Key Developments  Financial Performance  Strategies o Agilent Technologies  Company Highlights  Product Portfolio  Key Developments  Financial Performance o Strategies 12. Analyst Recommendations o Wheel of Fortune o Analyst View o Coherent Opportunity Map 13. References and Research Methodology o References o Research Methodology o About us *Browse 32 market data tables and 28 figures on 'Life Science Market' - Global forecast to 2033

提及公司

Thermo Fisher ScientificSiemens HealthineersAbbott LaboratoriesGE HealthcareRoche DiagnosticsMedtronicPhilips HealthcareJohnson & JohnsonBecton DickinsonDanaher CorporationPerkinElmerSartoriusMerck GroupIlluminaAgilent Technologies

同分類最新報告（醫療與生命科學）

常見問題

這份報告可以先索取樣本嗎？

可以。建議購買前先申請樣本，提出申請後約 2 個工作天內提供，您可以先確認內容涵蓋範圍是否符合需求。

報告價格如何計算？

報告以美元標價，台幣報價依當日匯率換算並加計 5% 營業稅。不同授權版本（單人／多人／企業全站）價格不同，量子訊息會評估您的使用情境後提供最優惠報價。

下單後多久交付？如何付款？

一般 3–7 個工作天交付，實際依出版商狀況於下單前確認。收到報告確認無誤後開立台幣發票，30 天內電匯付款即可。

量子訊息有限公司為 Coherent Market Insights 在台灣的授權代理，提供報告購買、樣本申請與授權諮詢。電話 +886 2 7751 5192 ・聯絡我們